Skip to main content


We're creating a new version of this page. See preview

  • Poster presentation
  • Open Access

Predictors of response to cardiac resynchronization therapy on pre-implantation cardiovascular magnetic resonance imaging

  • 1,
  • 1,
  • 2,
  • 1,
  • 2,
  • 2,
  • 1,
  • 1,
  • 2, 3 and
  • 1, 2
Journal of Cardiovascular Magnetic Resonance201315 (Suppl 1) :E40

  • Published:


  • Right Ventricular
  • Cardiovascular Magnetic Resonance
  • Cardiac Resynchronization Therapy
  • Late Gadolinium Enhancement
  • Right Ventricular Ejection Fraction


Cardiac resynchronization therapy (CRT) is an established treatment for severe heart failure. However, up to 40% of patients do not respond. While regional scar distribution has received focused attention, the predictive utility of global markers of remodeling and irreversible injury has not been well explored.


Sixty-eight patients receiving CRT underwent pre-implant cardiovascular MRI followed by serial echocardiography at 3 and 6 months. Blinded measurement of Left Ventricular (LV) and Right Ventricular (RV) chamber dimensions, volumes and mass were performed from short axis cine datasets. LV dysynchrony was measured by septal to lateral wall delay. Total LV scar burden was determined from Late Gadolinium Enhancement (LGE) images using manual contour tracing of endocardial and epicardial borders with application of a signal threshold ≥5SD above reference myocardium. Response to CRT was defined as a reduction in LV end-systolic volume (ESV) ≥15% at 6 months.


The mean age was 66.3 ± 8.9 years with a mean LV Ejection fraction (EF) of 25.2 ± 7.2%. Overall, 47 patients (69%) responded. Among all baseline measures LVEDV (p=0.03), LVESV (p=0.045), RV EF (p=0.0349) and total scar burden (p=0.018) were the only significant predictors of CRT response. Multivariate analysis showed total scar burden to be the only independent predictor of CRT response (p=0.015).


Pre-implantation MRI offers markers for the prediction of response to CRT. Of these, total scar burden appears to be an independent predictor of response and may be of assistance in the selection of optimal candidates.



Authors’ Affiliations

Medicine, London Health Sciences Centre, London, ON, Canada
Imaging Research Laboratory, Robarts Research Institute, Western University, London, ON, Canada
Medical Biophysics, Western University, London, ON, Canada


© Manian et al; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.